All sponsors

Chipscreen Biosciences, Ltd.

Clinical trial pipeline · active industry-sponsored Phase 1/2 to Phase 3 trials · updated 2026-11-19
ACTIVE TRIALS5
PHASE 3 / 2-33
RECRUITING3
READOUTS ≤12 MONTHS2
Open Chipscreen Biosciences, Ltd. on the live radar map →
TRIALPHASESTATUSCONDITIONNPRIMARY COMPLETION
Chiauranib
NCT06492915
P2Active, not recruitingPancreatic Ductal Adenocarcinoma422027-02-28 (+13 mo)
MECAP
NCT07129382
P1/2RecruitingPlaque Psoriasis2202027-09-18
Tucidinostat
NCT06497985
P3RecruitingColorectal Cancer4302028-05-31
Chiauranib
NCT07445295
P3Not yet recruitingMetastatic Pancreatic Ductal Adenocarcinoma5582028-06-30
CHOP (cyclophosphamide, hydroxydaunorubicin [doxorubicin], Oncovin [vincristine], prednisone)
NCT06947967
P3RecruitingLymphoma, T-Cell, Peripheral2242032-12 (+12 mo)